NO20074881L - 1,2,4-triazinderivater, fremstilling og anvendelse derav i human terapi - Google Patents
1,2,4-triazinderivater, fremstilling og anvendelse derav i human terapiInfo
- Publication number
- NO20074881L NO20074881L NO20074881A NO20074881A NO20074881L NO 20074881 L NO20074881 L NO 20074881L NO 20074881 A NO20074881 A NO 20074881A NO 20074881 A NO20074881 A NO 20074881A NO 20074881 L NO20074881 L NO 20074881L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- trifluoromethyl
- groups
- branched
- linear
- Prior art date
Links
- 150000003920 1,2,4-triazines Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- -1 hydroxycarbonylvinyl Chemical group 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- SSPYSWLZOPCOLO-UHFFFAOYSA-N 6-azauracil Chemical class O=C1C=NNC(=O)N1 SSPYSWLZOPCOLO-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000007942 carboxylates Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0502152A FR2882750B1 (fr) | 2005-03-03 | 2005-03-03 | Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine |
| PCT/FR2006/000469 WO2006092507A1 (fr) | 2005-03-03 | 2006-03-02 | Derives de 1 ,2,4-triazines, leur preparation et leur application en therapeutique humaine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074881L true NO20074881L (no) | 2007-11-27 |
Family
ID=35116027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074881A NO20074881L (no) | 2005-03-03 | 2007-09-25 | 1,2,4-triazinderivater, fremstilling og anvendelse derav i human terapi |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7713971B2 (pt) |
| EP (1) | EP1856065B1 (pt) |
| JP (1) | JP5269420B2 (pt) |
| KR (1) | KR20070112230A (pt) |
| CN (1) | CN101155790A (pt) |
| AR (1) | AR053155A1 (pt) |
| AT (1) | ATE448211T1 (pt) |
| AU (1) | AU2006219802A1 (pt) |
| BR (1) | BRPI0607567A2 (pt) |
| CA (1) | CA2599848A1 (pt) |
| CR (1) | CR9366A (pt) |
| DE (1) | DE602006010337D1 (pt) |
| ES (1) | ES2336823T3 (pt) |
| FR (1) | FR2882750B1 (pt) |
| IL (1) | IL185586A0 (pt) |
| MA (1) | MA29343B1 (pt) |
| MX (1) | MX2007010787A (pt) |
| MY (1) | MY140662A (pt) |
| NI (1) | NI200700224A (pt) |
| NO (1) | NO20074881L (pt) |
| PL (1) | PL1856065T3 (pt) |
| PT (1) | PT1856065E (pt) |
| RU (1) | RU2007136027A (pt) |
| TN (1) | TNSN07335A1 (pt) |
| TW (1) | TW200643016A (pt) |
| WO (1) | WO2006092507A1 (pt) |
| ZA (1) | ZA200707730B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2736229C (en) * | 2008-09-05 | 2015-06-09 | Acucela Inc. | Sulfur-linked compounds for treating opthalmic diseases and disorders |
| WO2012030165A2 (ko) | 2010-08-31 | 2012-03-08 | 서울대학교산학협력단 | P P A R δ 활성물질의 태자재프로그래밍용도 |
| JP6814730B2 (ja) * | 2014-09-05 | 2021-01-20 | ジェネンテック， インコーポレイテッド | 治療用化合物およびその使用 |
| TWI884745B (zh) * | 2018-10-12 | 2025-05-21 | 美商拓臻股份有限公司 | 甲狀腺素受體β促效劑化合物 |
| CN121081472A (zh) | 2018-12-13 | 2025-12-09 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| EP4017875A4 (en) | 2019-08-23 | 2023-05-03 | Terns Pharmaceuticals, Inc. | THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS |
| AU2020346057A1 (en) | 2019-09-12 | 2022-04-21 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| WO2024211898A1 (en) | 2023-04-07 | 2024-10-10 | Terns Pharmaceuticals, Inc. | Combination comprising a thrbeta agonist anda glp-1r agonist for use in treating a liver disorder or a cardiometabolic disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707294B1 (fr) * | 1993-07-06 | 1995-09-29 | Pf Medicament | Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine. |
| UA82048C2 (uk) * | 2000-11-10 | 2008-03-11 | Эли Лилли Энд Компани | Агоністи альфа-рецепторів, активованих проліфератором пероксисом |
| GB0113233D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
| FR2866339B1 (fr) * | 2004-02-18 | 2006-05-05 | Pf Medicament | Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine |
-
2005
- 2005-03-03 FR FR0502152A patent/FR2882750B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-02 PL PL06726008T patent/PL1856065T3/pl unknown
- 2006-03-02 US US11/885,630 patent/US7713971B2/en not_active Expired - Fee Related
- 2006-03-02 BR BRPI0607567-3A patent/BRPI0607567A2/pt not_active IP Right Cessation
- 2006-03-02 PT PT06726008T patent/PT1856065E/pt unknown
- 2006-03-02 MX MX2007010787A patent/MX2007010787A/es active IP Right Grant
- 2006-03-02 TW TW095107034A patent/TW200643016A/zh unknown
- 2006-03-02 WO PCT/FR2006/000469 patent/WO2006092507A1/fr not_active Ceased
- 2006-03-02 RU RU2007136027/04A patent/RU2007136027A/ru not_active Application Discontinuation
- 2006-03-02 AU AU2006219802A patent/AU2006219802A1/en not_active Abandoned
- 2006-03-02 AR ARP060100797A patent/AR053155A1/es unknown
- 2006-03-02 JP JP2007557542A patent/JP5269420B2/ja not_active Expired - Fee Related
- 2006-03-02 CA CA002599848A patent/CA2599848A1/fr not_active Abandoned
- 2006-03-02 ES ES06726008T patent/ES2336823T3/es not_active Expired - Lifetime
- 2006-03-02 KR KR1020077022414A patent/KR20070112230A/ko not_active Abandoned
- 2006-03-02 EP EP06726008A patent/EP1856065B1/fr not_active Expired - Lifetime
- 2006-03-02 AT AT06726008T patent/ATE448211T1/de not_active IP Right Cessation
- 2006-03-02 DE DE602006010337T patent/DE602006010337D1/de not_active Expired - Lifetime
- 2006-03-02 CN CNA2006800114913A patent/CN101155790A/zh active Pending
- 2006-03-03 MY MYPI20060914A patent/MY140662A/en unknown
-
2007
- 2007-08-29 IL IL185586A patent/IL185586A0/en unknown
- 2007-08-30 NI NI200700224A patent/NI200700224A/es unknown
- 2007-08-31 TN TNP2007000335A patent/TNSN07335A1/fr unknown
- 2007-09-04 CR CR9366A patent/CR9366A/es not_active Application Discontinuation
- 2007-09-10 ZA ZA200707730A patent/ZA200707730B/en unknown
- 2007-09-25 MA MA30243A patent/MA29343B1/fr unknown
- 2007-09-25 NO NO20074881A patent/NO20074881L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2336823T3 (es) | 2010-04-16 |
| RU2007136027A (ru) | 2009-04-10 |
| FR2882750A1 (fr) | 2006-09-08 |
| CA2599848A1 (fr) | 2006-09-08 |
| WO2006092507A8 (fr) | 2007-11-01 |
| AU2006219802A1 (en) | 2006-09-08 |
| EP1856065A1 (fr) | 2007-11-21 |
| MA29343B1 (fr) | 2008-03-03 |
| CN101155790A (zh) | 2008-04-02 |
| WO2006092507A1 (fr) | 2006-09-08 |
| CR9366A (es) | 2008-02-12 |
| FR2882750B1 (fr) | 2007-05-11 |
| PT1856065E (pt) | 2010-02-10 |
| JP2008531662A (ja) | 2008-08-14 |
| MY140662A (en) | 2010-01-15 |
| DE602006010337D1 (de) | 2009-12-24 |
| ATE448211T1 (de) | 2009-11-15 |
| JP5269420B2 (ja) | 2013-08-21 |
| KR20070112230A (ko) | 2007-11-22 |
| ZA200707730B (en) | 2008-05-28 |
| AR053155A1 (es) | 2007-04-25 |
| US7713971B2 (en) | 2010-05-11 |
| TNSN07335A1 (fr) | 2008-12-31 |
| MX2007010787A (es) | 2007-09-25 |
| EP1856065B1 (fr) | 2009-11-11 |
| PL1856065T3 (pl) | 2010-04-30 |
| TW200643016A (en) | 2006-12-16 |
| US20080167313A1 (en) | 2008-07-10 |
| NI200700224A (es) | 2008-03-27 |
| IL185586A0 (en) | 2008-01-06 |
| BRPI0607567A2 (pt) | 2011-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074881L (no) | 1,2,4-triazinderivater, fremstilling og anvendelse derav i human terapi | |
| MY145140A (en) | Amide derivatives, process for preparation thereof and use thereof as insecticide | |
| NO20083434L (no) | Benzamid- og heteroarenderivater | |
| CA2582447A1 (en) | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
| AR062109A1 (es) | Derivados sustituidos de espirocetal y uso de los mismos como farmacos terapeuticos para la diabetes. composiciones farmaceuticas. | |
| UY31507A1 (es) | Derivados de piridina activadores de guanilato ciclasa soluble | |
| ECSP077185A (es) | Derivados de piridina | |
| MX2010005299A (es) | Derivados de bis-(sulfonilamino) en terapia 066. | |
| DK1533292T3 (da) | Dibenzylaminforbindelse og medicinsk anvendelse deraf | |
| CO5700757A2 (es) | Derivados de (3-oxo-3,4-dihidro-quinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad | |
| MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
| CY1114932T1 (el) | Αντιπαρασιτικοι παραγοντες | |
| NO20093275L (no) | 1,3-Dihydroimidazol-2-thione derivater som inhibitorer av dopamin-beta-hydroksylase | |
| AR041299A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
| CY1116190T1 (el) | Φαρμακευτικη συνθεση η οποια περιεχει οπτικα ενεργη ενωση που διαθετει δραστικοτητα αγωνιστη υποδοχεα θρομβοποιητινης και ενδιαμεσο γι' αυτην | |
| PE20090880A1 (es) | Compuestos heterociclicos como inhibidores de fosfatidilinositol 3-cinasa | |
| DE602006011752D1 (de) | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate | |
| TW200745032A (en) | Novel heterobicyclic derivatives | |
| UA81561C2 (en) | Use of n-arylhydrazine derivative and method for controlling non-crop pests | |
| PE20040907A1 (es) | Derivados de anilinopirazol | |
| AR056574A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ | |
| EA200700103A1 (ru) | НОВЫЕ 2-ЗАМЕЩЁННЫЕ D-ГОМО-ЭСТРА-1,3,5(10)-ТРИЕНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ 17β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ ТИПА 1 | |
| CO6180505A2 (es) | Metodos para el tratamiento de transtornos cocleares y vestibulares |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |